Synthesis and preclinical evaluation of novel 18F-labeled Glu-urea-Glu-based PSMA inhibitors for prostate cancer imaging: a comparison with 18F-DCFPyl and 18F-PSMA-1007.
about
Synthesis and preclinical evaluation of novel 18F-labeled Glu-urea-Glu-based PSMA inhibitors for prostate cancer imaging: a comparison with 18F-DCFPyl and 18F-PSMA-1007.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Synthesis and preclinical eval ...... 18F-DCFPyl and 18F-PSMA-1007.
@en
Synthesis and preclinical eval ...... 18F-DCFPyl and 18F-PSMA-1007.
@nl
type
label
Synthesis and preclinical eval ...... 18F-DCFPyl and 18F-PSMA-1007.
@en
Synthesis and preclinical eval ...... 18F-DCFPyl and 18F-PSMA-1007.
@nl
prefLabel
Synthesis and preclinical eval ...... 18F-DCFPyl and 18F-PSMA-1007.
@en
Synthesis and preclinical eval ...... 18F-DCFPyl and 18F-PSMA-1007.
@nl
P2093
P2860
P1433
P1476
Synthesis and preclinical eval ...... 18F-DCFPyl and 18F-PSMA-1007.
@en
P2093
Alexander Schmidt
Behrooz Hooshyar Yousefi
Hans-Jürgen Wester
Margret Schottelius
Markus Schwaiger
Matthias Eiber
Stephanie Robu
Thomas Günther
P2860
P2888
P356
10.1186/S13550-018-0382-8
P577
2018-04-12T00:00:00Z
P6179
1103243408